Fennec Pharmaceuticals Inc.
FENC- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001211583
In the last 90 days, Fennec Pharmaceuticals Inc. insiders filed 0 open-market purchases and 5 sales; 105 institutions reported holding it in 13F filings for Q2 2026, worth $175.1M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Fennec Pharmaceuticals Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 32 | 1 | 30 | −1 |
| Shares | 11.6M | 1.00K | 11.3M | −300.3K (−2.6%) |
| Value | $109.7M | $10.0K | $49.9M | −$59.8M (−54.5%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (7)
Institutions that held Fennec Pharmaceuticals Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Tamar Securities, LLC | 53,475 | $235.0K | 0.07% |
| Wealthspire Advisors, LLC | 25,000 | $110.0K | 0.00% |
| Citadel Advisors LLC | 14,874 | $65.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 5,970 | $26.0K | 0.00% |
| Fortitude Advisory Group L.L.C. | 1,500 | $7.00K | 0.00% |
| TD Waterhouse Canada Inc. | 555 | $2.50K | 0.00% |
| JPMorgan Chase & Co | 70 | $0 | 0.00% |
Sold out (8)
Institutions that held Fennec Pharmaceuticals Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Ergoteles LLC | 91,434 | $861.0K |
| HRT Financial LP | 55,935 | $526.0K |
| Russell Investments Group, Ltd. | 31,728 | $298.0K |
| Belvedere Trading LLC | 17,790 | $155.0K |
| Parametric Portfolio Associates LLC | 10,994 | $104.0K |
| Barclays PLC | 2,648 | $25.0K |
| Group One Trading, L.P. | 1,600 | $15.0K |
| Wells Fargo & Company | 1,400 | $13.0K |
Not filed for Q4 2021 yet (1)
Institutions that held Fennec Pharmaceuticals Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Wealth Quarterback LLC | 1,000 | $10.0K |